The estimated Net Worth of Andrew Kenneth William Powell is at least $588 Tysiąc dollars as of 1 June 2024. Mr. Powell owns over 4,660 units of Lifecore Biomedical Inc stock worth over $293,661 and over the last 15 years he sold LNDC stock worth over $91,392. In addition, he makes $202,792 as Independent Director at Lifecore Biomedical Inc.
Andrew has made over 13 trades of the Lifecore Biomedical Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 4,660 units of LNDC stock worth $40,822 on 1 June 2024.
The largest trade he's ever made was buying 14,500 units of Lifecore Biomedical Inc stock on 1 March 2024 worth over $17,980. On average, Andrew trades about 1,527 units every 124 days since 2009. As of 1 June 2024 he still owns at least 33,523 units of Lifecore Biomedical Inc stock.
You can see the complete history of Mr. Powell stock trades at the bottom of the page.
Andrew Kenneth William Powell J.D. serves as Independent Director of the Company. Mr. Powell is currently serving as an independent advisor to small and mid-size companies and research institutions in the life sciences sector. He has served on the Board of Directors of Aclaris Therapeutics, Inc., a dermatologist-led biopharmaceutical company, since 2017. He served as Senior Vice President, General Counsel and Corporate Secretary of Medivation, Inc. from May 2015 until November 2016, when the company was acquired by Pfizer, Inc. Mr. Powell served as Executive Vice President, General Counsel and Corporate Secretary of InterMune, Inc. from September 2013 to March 2015. From 2009 to 2013, he served as Executive Vice President, General Counsel and Secretary at Cornerstone Therapeutics, Inc. From 2008 to 2009, Mr. Powell served as Senior Vice President and General Counsel at ImClone Systems, Inc. From 2004 to 2008, he was General Counsel at Collagenex Pharmaceuticals, Inc. Earlier in his career, Mr. Powell held positions of increasing responsibility for nearly 15 years at the multi-national healthcare company Baxter International, Inc., where he was instrumental in a series of transactions that established Baxter throughout Asia.
As the Independent Director of Lifecore Biomedical Inc, the total compensation of Andrew Powell at Lifecore Biomedical Inc is $202,792. There are 9 executives at Lifecore Biomedical Inc getting paid more, with Dr. Albert D. Bolles Ph.D. having the highest compensation of $989,459.
Andrew Powell is 62, he's been the Independent Director of Lifecore Biomedical Inc since 2020. There are 6 older and 13 younger executives at Lifecore Biomedical Inc. The oldest executive at Lifecore Biomedical Inc is Charles Macaluso, 76, who is the Independent Director.
Andrew's mailing address filed with the SEC is C/O ACLARIS THERAPEUTICS, INC., 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087.
Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp... oraz Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Lifecore Biomedical Inc executives and other stock owners filed with the SEC include: